Eterna Therapeutics Inc (NASDAQ:ERNA)’s traded shares stood at 0.55 million during the last session, with the company’s beta value hitting 4.49. At the close of trading, the stock’s price was $0.34, to imply a decrease of -1.24% or $0.0 in intraday trading. The ERNA share’s 52-week high remains $2.62, putting it -670.59% down since that peak but still an impressive 35.29% since price per share fell to its 52-week low of $0.22. The company has a valuation of $17.25M, with an average of 0.62 million shares in intraday trading volume over the past 10 days and average of 11.13 million shares over the past 3 months.
Eterna Therapeutics Inc (NASDAQ:ERNA) trade information
After registering a -1.24% downside in the last session, Eterna Therapeutics Inc (ERNA) has traded red over the past five days. The 5-day price performance for the stock is -11.26%, and 0.72% over 30 days. With these gigs, the year-to-date price performance is 14.22%. Short interest in Eterna Therapeutics Inc (NASDAQ:ERNA) saw shorts transact 44458.0 shares and set a 1.07 days time to cover.
ERNA Dividends
Eterna Therapeutics Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Eterna Therapeutics Inc (NASDAQ:ERNA)’s Major holders
Eterna Therapeutics Inc insiders hold 336.35% of total outstanding shares, with institutional holders owning 11.00% of the shares at -4.65% float percentage. In total, 11.00% institutions holds shares in the company.
We also have Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Eterna Therapeutics Inc (ERNA) shares. Going by data provided on Sep 30, 2024 , Vanguard Extended Market Index Fund holds roughly 26.1 shares. This is just over 0.05% of the total shares, with a market valuation of $8764.0. Data from the same date shows that the other fund manager holds a little less at 13.1, or 0.03% of the shares, all valued at about 4397.0.
